Our researchers - Professor Matthew Snape

Default Profile

Professor Matthew Snape

Professor in General Paediatrics and Vaccinology

University of Oxford

Department of Paediatrics


Oxford Vaccine Group

Contributing to research themes:

Matthew Snape, MBBS FRCPCH MD, is an Associate Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council.  He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust.

Assoc. Prof. Snape's is an Investigator on clinical research studies related to COVID-19, meningococcal, pneumococcal, influenza, RSV and Ebola virus disease. In 2014/2015 he was the Chief Investigator on a 'first in human' phase 1 study of a candidate Ebola virus disease, providing data crucial to the subsequent licensing of this vaccine by the EMA. He is currently the Chief Investigator of the 'Be on the TEAM' study enrolling 24 000 Year 12 students to evaluate the impact of immunisation with group B meningococcal vaccines on pharyngeal carriage of meningococcus, and the ‘What’s the STORY’ study evaluating rates of COVID-19 infection in children, both of which are NIHR funded.

Other projects include leading on the instigation of the Global Platform for Prevention of Autoimmune Diabetes (GPPAD) in the UK and acting as a Chief or Principal Investigator on clinical trials of multiple RSV vaccine candidates.